"Testicular Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.
- Testicular Neoplasms
- Neoplasm, Testicular
- Testicular Neoplasm
- Testicular Tumors
- Testis Neoplasms
- Neoplasms, Testicular
- Neoplasms, Testis
- Neoplasm, Testis
- Testis Neoplasm
Tumor of Rete Testis
- Tumor of Rete Testis
- Rete Testis Tumor
- Rete Testis Tumors
- Testis Tumor, Rete
- Testis Tumors, Rete
Cancer of Testis
- Cancer of Testis
- Testis Cancers
- Testis Cancer
- Cancer, Testis
- Cancers, Testis
- Cancer of the Testes
- Cancer of the Testis
- Testicular Cancer
- Cancer, Testicular
- Cancers, Testicular
- Testicular Cancers
Below are MeSH descriptors whose meaning is more general than "Testicular Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Testicular Neoplasms".
This graph shows the total number of publications written about "Testicular Neoplasms" by people in this website by year, and whether "Testicular Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Testicular Neoplasms" by people in Profiles.
Gamut of Extratesticular Scrotal Masses: Anatomic Approach to Sonographic Differential Diagnosis. Radiographics. 2023 Apr; 43(4):e220113.
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study. Eur J Cancer. 2023 Mar; 182:144-154.
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy. J Cancer Surviv. 2023 Feb; 17(1):27-39.
Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study. Urol Oncol. 2023 02; 41(2):111.e7-111.e14.
Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium. Br J Cancer. 2022 11; 127(9):1577-1583.
Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting. J Mol Diagn. 2022 08; 24(8):867-877.
ACR Appropriateness Criteria? Staging and Surveillance of Testicular Cancer: 2021 Update. J Am Coll Radiol. 2022 05; 19(5S):S194-S207.
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial. Lancet. 2022 04 30; 399(10336):1718-1729.
Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy. Cancer Med. 2022 07; 11(14):2801-2816.
Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility. World J Urol. 2022 Jun; 40(6):1505-1512.